sur Quantum Biopharma Ltd.
Quantum Biopharma Ltd. to Dual List on Upstream Market
Quantum BioPharma Ltd., a biopharmaceutical company, announced its shares will be dual listed on Upstream, a MERJ Exchange market and securities trading app. Trading will commence on January 14, 2025, under the symbol 'QNTM'. This strategic move aims to expand Quantum's investor base globally, providing liquidity and enhancing price discovery.
International investors can trade using various payment methods, including credit cards, PayPal, and cryptocurrencies. The Upstream platform offers real-time trading with a transparent order book designed to prevent market manipulations.
Quantum's CEO, Zeeshan Saeed, stated, "Dual listing supports our goal of building shareholder value as we develop treatments for neurodegenerative and metabolic disorders." Full trading instructions are available on Quantum's website.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Quantum Biopharma Ltd.